GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (FRA:0JZ) » Definitions » Valuation Rank

Affluent Medical (FRA:0JZ) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Affluent Medical Valuation Rank Related Terms

Thank you for viewing the detailed overview of Affluent Medical's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Affluent Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (FRA:0JZ) » Definitions » Valuation Rank
Comparable Companies
XPAR:ALMDT XPAR:ALCAR XPAR:ALNOV XPAR:ALBIO XPAR:ALIKO XPAR:ALDMS XPAR:ALIMP XPAR:ALMKT XPAR:ALBLU XPAR:ALTHE ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
AFME:France 0JZ:Germany
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Website
https://www.affluentmedical.com
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.